AI in drug discovery uses models to predict how molecules and proteins behave, helping scientists find and design promising medicines faster.
In plain words
Finding a new drug means searching a vast space of possible molecules for one that binds the right target, is safe and can be made. AI helps by predicting protein shapes, how molecules might interact, and which candidates to test first. Regulators such as the FDA report a sharp rise in drug applications that include AI components.
A quick example
Researchers want a molecule that blocks a disease protein. They use a structure model to see the protein's pockets, then a generative model proposes candidate molecules. The team tests only the most promising few in the lab, instead of thousands.
Where you'll meet it
- Early discovery: picking targets and designing molecules.
- Later stages: clinical work, manufacturing and after-market monitoring.
Related
Sources
- DocsArtificial Intelligence for Drug Development, U.S. Food and Drug Administration · read 29 Sept 2026
- DocsIsomorphic Labs, Isomorphic Labs · read 12 Nov 2026
- PaperAccurate structure prediction of biomolecular interactions with AlphaFold 3, Abramson et al. (Nature) · read 29 Sept 2026
Checked by WhatIsAI against the sources above · 12 Nov 2026. Spotted an error? Report it.